All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
Body Protection Compound-157
For educational and research purposes only. Not medical advice.
BPC-157 is one of the most extensively studied healing peptides with over 40 animal trials showing significant tissue repair across tendons, ligaments, muscles, and the GI tract. Human trial data is limited but emerging, with strong community-reported outcomes for injury recovery.
Best Time
Morning or split AM/PM
Method
subcutaneous
Frequency
1-2x daily
Half-life
~4 hours
Cycle Length
4-6 weeks
Storage
Refrigerate reconstituted vial at 2-8°C. Use within 30 days.
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
The gold standard healing stack. BPC-157 works locally at injury sites while TB-500 provides systemic repair. Together they accelerate recovery significantly.
documentedGH release from Ipamorelin supports the tissue repair mechanisms of BPC-157. Popular combination for recovery-focused protocols.
communityBPC-157's tissue repair pairs well with GHK-Cu's collagen and growth factor stimulation. Both promote angiogenesis through different pathways for comprehensive wound healing.
communityBoth are tissue-protective peptides. Pentadecarginine enhances nitric oxide signaling and blood flow while BPC-157 promotes angiogenesis and tissue repair through complementary pathways.
communityGH pulses from Mod GRF 1-29 amplify BPC-157's healing cascade. The increased IGF-1 from GH release supports tissue regeneration.
communityBPC-157's local gut/tendon repair pairs with full-length Thymosin Beta-4's systemic healing and anti-inflammatory effects. Different receptors and mechanisms for comprehensive recovery.
communityKPV (alpha-MSH fragment) suppresses NF-κB-driven inflammation while BPC-157 promotes tissue repair and angiogenesis. Popular gut-healing combination for inflammatory bowel conditions.
communityBPC-157's tissue repair combined with Thymosin Alpha-1's immune modulation. Theoretical synergy for healing in immunocompromised contexts.
theoreticalBPC-157's tissue repair and cytoprotection combined with LL-37's antimicrobial and wound-healing properties. Theoretical synergy for injury recovery where infection risk is present.
theoreticalCurrent pharmaceutical design 23 (27) :4029-4041 · 2017-01-01
The American journal of sports medicine 54 (1) :223-229 · 2026-01-01
Journal of pharmaceutical policy and practice 18 (1) :2441220 · 2025-01-01
Sports medicine (Auckland, N.Z.) · 2026-04-12
Molecules (Basel, Switzerland) 28 (21) · 2023-10-30
Mechanism of Action
Promotes angiogenesis (new blood vessel formation), modulates nitric oxide synthesis, and upregulates growth hormone receptors. Activates the FAK-paxillin pathway for wound healing.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.